
Nashville Business Journal Names RxPreferred CEO Among 2025 C-Suite Awards Finalists
We’re proud to share that our CEO, Jeff Malone, has been named a finalist in the Nashville Business Journal’s C-Suite Awards. This recognition reflects Jeff’s exceptional leadership and the continued progress RxPreferred is making in advancing transparency, affordability, and innovation within pharmacy benefits.

RxPreferred named one of Nashville Business Journal‘s– Fastest Growing Companies of 2025
RxPreferred News Subscribe RxPreferred named one of Nashville Business Journal‘s– Fastest Growing Companies of 2025 We’re excited to announce the honorees of the 2025 Fastest-Growing Companies Awards. This award recognizes the fastest-growing private companies in Middle Tennessee, as determined by revenue.

RxPreferred Launches My-RxP: Cutting Costs for Brand, Specialty, GLP-1, and Fertility Medications by Up to 60%
RxPreferred, a leading transparent pharmacy benefit administrator, is proud to announce the launch of My-RxP, an innovative medication savings program designed to help employers dramatically reduce the cost of high-cost Brand and Specialty medications, including GLP-1s for weight management and Fertility treatments.

Shining a Light on Transparency: RxPreferred on Viewpoint with Dennis Quaid
Our feature on Viewpoint Project with Dennis Quaid is officially airing nationwide across Public Television stations, shining a national spotlight on RxPreferred and the growing movement for transparency in pharmacy benefit management.

RxPreferred Unveils RxP-AI: AI-Powered Pharmacy Benefits Platform to Cut Drug Costs.
RxPreferred, a leader in transparent pharmacy benefits administration, introduces RxP-AI, an AI-powered platform designed to optimize benefits management and lower costs.

RxPreferred Revolutionizes Healthcare Affordability with Launch of AI-Based Savings Program, Rx-Performance
RxPreferred, a leading pharmacy benefits administrator and advocate for transparent, cost-effective healthcare solutions, continues its push for lower drug costs and improved accessibility for clients and members through Rx-Performance, an initiative geared towards further lowering patient out-of-pocket costs.